BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15123284)

  • 1. Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity.
    Buey RM; Díaz JF; Andreu JM; O'Brate A; Giannakakou P; Nicolaou KC; Sasmal PK; Ritzén A; Namoto K
    Chem Biol; 2004 Feb; 11(2):225-36. PubMed ID: 15123284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.
    Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF
    Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.
    Feyen F; Cachoux F; Gertsch J; Wartmann M; Altmann KH
    Acc Chem Res; 2008 Jan; 41(1):21-31. PubMed ID: 18159935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
    Kamath K; Jordan MA
    Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Much anticipated--the bioactive conformation of epothilone and its binding to tubulin.
    Heinz DW; Schubert WD; Höfle G
    Angew Chem Int Ed Engl; 2005 Feb; 44(9):1298-301. PubMed ID: 15714588
    [No Abstract]   [Full Text] [Related]  

  • 6. Scaffolds for microtubule inhibition through extensive modification of the epothilone template.
    Cachoux F; Isarno T; Wartmann M; Altmann KH
    Angew Chem Int Ed Engl; 2005 Dec; 44(45):7469-73. PubMed ID: 16240301
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epothilone analogues with benzimidazole and quinoline side chains: chemical synthesis, antiproliferative activity, and interactions with tubulin.
    Dietrich SA; Lindauer R; Stierlin C; Gertsch J; Matesanz R; Notararigo S; Díaz JF; Altmann KH
    Chemistry; 2009 Oct; 15(39):10144-57. PubMed ID: 19697384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of the activity of the microtubule-stabilizing agent epothilone a studied by NMR spectroscopy in solution.
    Reese M; Sánchez-Pedregal VM; Kubicek K; Meiler J; Blommers MJ; Griesinger C; Carlomagno T
    Angew Chem Int Ed Engl; 2007; 46(11):1864-8. PubMed ID: 17274084
    [No Abstract]   [Full Text] [Related]  

  • 10. The binding mode of side chain- and C3-modified epothilones to tubulin.
    Erdélyi M; Navarro-Vázquez A; Pfeiffer B; Kuzniewski CN; Felser A; Widmer T; Gertsch J; Pera B; Díaz JF; Altmann KH; Carlomagno T
    ChemMedChem; 2010 Jun; 5(6):911-20. PubMed ID: 20432490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A.
    Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative binding energy (COMBINE) analysis supports a proposal for the binding mode of epothilones to β-tubulin.
    Coderch C; Klett J; Morreale A; Fernando Díaz J; Gago F
    ChemMedChem; 2012 May; 7(5):836-43. PubMed ID: 22431398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography.
    Nettles JH; Li H; Cornett B; Krahn JM; Snyder JP; Downing KH
    Science; 2004 Aug; 305(5685):866-9. PubMed ID: 15297674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making epothilones fluoresce: design, synthesis, and biological characterization of a fluorescent N12-aza-epothilone (azathilone).
    Gertsch J; Feyen F; Bützberger A; Gerber B; Pfeiffer B; Altmann KH
    Chembiochem; 2009 Oct; 10(15):2513-21. PubMed ID: 19760690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five new epothilone metabolites from Sorangium cellulosum strain So0157-2.
    Wang J; Zhang H; Ying L; Wang C; Jiang N; Zhou Y; Wang H; Bai H
    J Antibiot (Tokyo); 2009 Sep; 62(9):483-7. PubMed ID: 19575038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cyclopropane configuration on the biological activity of cyclopropyl-epothilones.
    Gaugaz FZ; Redondo-Horcajo M; Barasoain I; Díaz JF; Cobos-Correa A; Kaufmann M; Altmann KH
    ChemMedChem; 2014 Oct; 9(10):2227-32. PubMed ID: 25045073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone.
    Wang M; Xia X; Kim Y; Hwang D; Jansen JM; Botta M; Liotta DC; Snyder JP
    Org Lett; 1999 Jul; 1(1):43-6. PubMed ID: 10822530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
    Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
    Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies.
    Magnani M; Ortuso F; Soro S; Alcaro S; Tramontano A; Botta M
    FEBS J; 2006 Jul; 273(14):3301-10. PubMed ID: 16803461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
    Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.